| 000 | 01174 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513200544.0 | ||
| 264 | 0 | _c20000113 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI9053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSellers, W R | |
| 245 | 0 | 0 |
_aApoptosis and cancer drug targeting. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cDec 1999 |
||
| 300 |
_a1655-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNF-kappa B _xdrug effects |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xdrug effects |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xdrug effects |
| 650 | 0 | 4 | _aProto-Oncogene Proteins |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 700 | 1 | _aFisher, D E | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 104 _gno. 12 _gp. 1655-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI9053 _zAvailable from publisher's website |
| 999 |
_c10562627 _d10562627 |
||